Transcript Slide 1

Arthropods Attacks
II
IHAB YOUNIS, M.D.
Leishmaniasis
After Sir William Leishman (1865–1926),
British medical officer
The typical lesions of cutaneous leishmaniasis
were described as early as 900 BC and have
been referred to as the "Balkan sore" in the
Balkans, the "Delhi boil" in India, the "Baghdad
boil" in Iraq, and "saldana" in Afghanistan
Etiology


approximately 1.5 million new cases of
cutaneous leishmaniasis and 500,000 cases
of visceral leishmaniasis occur worldwide
each year
Incidence is highest in tropical and
subtropical regions where conditions are
favorable for sandflies
Causative agent



Within the female sandfly gut, the protozoa
multiply and migrate toward the pharynx
As the leishmaniae replicate, they create a
blockage in the fly's esophagus. The sandfly
then clears out its esophagus by expelling
leishmaniae into the skin of the host, from where
they pass into the blood and tissues of the
human host
They are phagocytosed into macrophages of
the reticuloendothelial system, where they
multiply by binary fission

When the infected cells rupture, the infection
spreads to other macrophages and is carried
throughout the body

Temperature is an important factor that helps
determine the localization of leishmanial
lesions. Species causing visceral
leishmaniasis are able to grow at core
temperatures, while those responsible for
cutaneous leishmaniasis grow best at lower
temperatures
Types

Cutaneous leishmaniasis

Mucocutaneous leishmaniasis

Visceral leishmaniasis
Cutaneous leishmaniasis
Causative agents
-
-
Old world :
Leishmania tropica
Leishmania major
Leishmania infantum
Leishmania aethiopica
Clinically



Initial lesions can appear immediately after a
bite, or the incubation period may last for
several months
Systemic signs usually are absent
Ulcers usually are found on exposed areas of
skin, especially the extremities and face

Lesions can be single or multiple

Initially, the lesion is a small, red papule up to
2 cm in diameter. Over several weeks, the
papule becomes darker and will crust in the
center, eventually ulcerating
The ulcer shows raised edges and surrounding dusky
red skin The ulcers can be moist or open with
seropurulent exudate or dry with a crusted scab



After about 3-6 months,
the ulcers heal, leaving
a raised border
Regional adenopathy,
satellite lesions, and
subcutaneous nodules
can be present
Untreated sores can
leave depigmented
retracted scars
Mucocutaneous
leishmaniasis
Mucosal lesions can progress to involve the
entire nasal mucosa and the hard and soft
palates
Without treatment, nasal
mucosa and palates
become deformed with
ulceration and erosion
 Bones are spared but
there is severe
disfigurement
Visceral leishmaniasis




Bouts of fever
Hepatosplenomegaly
Darkening of the skin
is characteristic (thus,
the name kala azar
or black fever in Assamese )
Patients may die of
hemorrhage, severe anemia or secondary
bacterial infections
Histopathology
Lab studies

Direct evidence of infection
1-Peripheral blood smear: amastigotes are
seen inside monocytes and neutrophils
2-Culture on NNN medium : takes about a
month
3-Animal inoculation: a sensitive method but
can take several weeks

Indirect evidence of infection
1-Detection of hypergammaglobinemia for Kala
azar
2-Detection of IgM antibody
3-Leishmanin skin test (Montenegro test) is a
delayed hypersensitivity reaction.
- Intradermally, 0.1 mL of killed promastigote
antigen are injected. The test is read after 72 hours
- The leishmanin skin is negative during active
visceral leishmaniasis and usually becomes
positive only after successful therapy
- It also is positive in dermal leishmaniasis. This test
is useful only for epidemiological purposes,
indicating prior exposure to infection
Treatment
Sodium stibogluconate (Pentostam 100
mg/ml)

For all forms of the disease, treatment should
be started with a 200-mg test dose and then
followed by daily injections of 20 mg/kg IV
(preferably) or IM

Intralesional Pentostam(0.2-0.8 ml) is
effective but injection is painfull

Cutaneous disease should be treated for 20 d

Mucocutaneous and visceral disease should
be treated for 28 d

May cause myalgias and arthralgias (50%),
fever, phlebitis, rash, and GI symptoms
Meglumine antimoniate(Glucantime
300 mg/ml)
Dosed exactly the same and is equivalent in
efficacy and toxicity to sodium stibogluconate
Amphotericin B (AmBisome)

A second-line drug to be used after failure of
antimonials to treat mucocutaneous and
visceral leishmaniasis

Given as a slow infusion (4-6 h) of 1 mg/kg
qd for 20 d

Oral drugs such as ketoconazole,
itraconazole, and allopurinol also are
effective but only in combination with the firstline drugs

Other approaches include surgical excision
and cryotherapy
Jellyfish Stings
Etiology


With more than 10,000 species in the sea,
jellyfish are responsible for the most common
human envenomations
More than 100 species are toxic to humans

The tentacles are covered with specialized
stinging cells termed nematocytes

Each nematocyte contains a stinging
apparatus known as the nematocyst

The stinging process of the nematocyte
resembles a jack-in-the-box mechanism:
stimulation of the sensory hairs surrounding
the pressurized nematocyte results in a
calcium-mediated bioelectric signal that
causes an opening of its lid, allowing the
ejection of the nematocyst into the prey to
express the venom

The nematocyst is capable of penetrating up
to a depth of 0.9 mm. This depth deposits the
toxin into the microvasculature of the dermal
tissue to be absorbed into the systemic
circulation of the prey

The nematocysts' size and arrangement on
jellyfish tentacles differ from species to
species which is reflected in the skin pattern
left via the sting
Composition of venom

catecholamines, vasoactive amines (eg,
histamine, serotonin), kinins, collagenases,
hyaluronidases, proteases, phospholipases,
fibrinolysins, dermatoneurotoxins,
cardiotoxins, neurotoxins, nephrotoxins,
myotoxins, and antigenic proteins
Clinically

Toxicity and variations of symptoms depend
on several factors.






Patient age and health
Patient body weight relative to the toxin amount
Patient surface area involved in the sting (any
sting >50% of limb area is associated with severe
envenomation)
Thickness of the skin at contact points
Site of envenomation (proximity to head=quicker
venom absorption into central circulation)
Species and maturity of the jellyfish



Hot water sensation with skin tingling or
stinging may be reported at the body site
where the jellyfish originally made contact
Tenderness, burning, and pruritus, which may
spread centrally and differ in intensity
depending on the species involved
Erythematous papules and blisters in a
whiplike pattern with desquamation within 1-8
weeks



Local neuropraxia occurring adjacent to sting
site from immunologic reaction to toxin or to
toxin-induced alteration of the nerve's ionic
permeability
Tender regional lymphadenopathy
Distant skin site reactions secondary to a
hypersensitive response to the antigenic
component of the venom
Long-term skin effects








Keloids
Pigmented striae
Lichenification from persistent rubbing
Granuloma
Ulceration and necrosis
Gangrene
Fat atrophy
Scarring and contractures
Systemic effects




Cardiovascular: Peripheral and coronary
vasospasm&heart failure or arrhythmia
Respiratory:Laryngeal edema,bronchospasm,
respiratory failure
Neurologic:Autonomic dysfunction,spastic
paralysis Cerebral edema, seizures, headache,
agitation, coma
Gastrointestinal:Nausea and
vomiting,abdominal muscle rigidity and
pain,hepatic inflammatory necrosis from direct
toxin injury to hepatocytes
Lab Studies




CBC count to evaluate toxin-induced hemolysis
Electrolyte levels, BUN/creatine ratio, and
glucose levels to determine if an abnormality is
present that can worsen the toxin-induced
muscular paresis
Liver function tests, which are elevated because
of toxin-induced liver inflammation
Others according to case e.g. EEG
Treatment
Local skin treatment

Rinse the wound with sterile normal
saline to prevent nematocyte
activation(seawater carries marine
pathogens). Avoid using fresh water and
rubbing the skin, since these activities
trigger unfired nematocytes

Soak the wound in 5% acetic acid for 1530 minutes to further inhibit nematocyte
discharge



After the inactivation, carefully remove any
visible tentacles with forceps
Administer systemic antibiotics if signs of
secondary infection exist
Apply topical anesthetics once the
nematocytes/nematocysts are removed.
Cold pack compresses at the sting site for
5-10 minutes relieve all but the most
severe site pain. Avoid direct application of
ice to the area, since the hypotonic water
from the melting ice may stimulate
unremovable, unfired nematocytes. Also,
avoid hot compresses, since they increase
systemic uptake of venom

Administer antihistamines and topical and
systemic corticosteroids for severe local
reactions as well as to decrease the probability
of serum sickness

Administer muscle relaxants(eg,benzodiazepine,
methocarbamol) for severe local spasms

Narcotic analgesias are appropriate for severe
local pain not responding to topical anesthetics.

Administer a tetanus shot as a prophylactic
measure
Other systems e.g.

Apply a lymphatic-venous compression
bandage proximally to the sting site

Provide supportive care (eg, central venous
monitoring, fluids)

Ophthalmic care
Surgical Care
Once the nematocytes are inactivated, they
can be removed by dusting the area with a
paste of shaving cream, baking soda, and
talc for 1 hour to coalesce the nematocyte,
followed by scraping the area with a dull
object (eg, spoon). Strong adhesive tape
applied to the area and then removed also
can be used